Gramegna Andrea
Associate Professor
Scientific-Disciplinary Sector
MEDS-07/A - Respiratory Diseases
Scientific-Disciplinary Group/Competition Sector
06/MEDS-07 - MALATTIE DELL'APPARATO CARDIOVASCOLARE E MALATTIE DELL'APPARATO RESPIRATORIO
Research fields and competencies
Contacts
Workplace
Additional phone numbers
University email address
Teaching - Programme courses
Bachelors and masters
A.Y. 2025/2026
A.Y. 2024/2025
A.Y. 2023/2024
A.Y. 2022/2023
A.Y. 2021/2022
A.Y. 2020/2021
Postgraduate programmes
A.Y. 2024/2025
1st level vocational master
- Cardiorespiratory Anatomy and Physiology (Cardiorespiratory and Critical Care Physiotherapy)
- Respiratory Rehabilitation in Hypersecretive Patients (Cardiorespiratory and Critical Care Physiotherapy)
A.Y. 2023/2024
1st level vocational master
- Cardiorespiratory Anatomy and Physiology (Cardiorespiratory and Critical Care Physiotherapy)
- Respiratory Rehabilitation in Hypersecretive Patients (Cardiorespiratory and Critical Care Physiotherapy)
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
- Malattie dell'apparato respiratorio 1 (Postgraduate School of Respiratory Medicine)
- Malattie dell'apparato respiratorio 2 (Postgraduate School of Respiratory Medicine)
- Malattie dell'apparato respiratorio 3 (Postgraduate School of Respiratory Medicine)
- Malattie dell'apparato respiratorio 4 (Postgraduate School of Respiratory Medicine)
A.Y. 2022/2023
1st level vocational master
- Cardiorespiratory Anatomy and Physiology (Fisioterapia Cardiorespiratoria E Di Area Critica)
- Respiratory Rehabilitation in Hypersecretive Patients (Fisioterapia Cardiorespiratoria E Di Area Critica)
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
- Malattie dell'apparato respiratorio 1 (Postgraduate School of Respiratory Medicine)
Research
Publications
-
Impact of elexacaftor/tezacaftor/ivacaftor (ETI) on the prescription refill rate (PRR) for inhaled medications in people with CF: an Italian multicenter analysis / A. Gramegna, G. Cimino, M. Cipolli, G. Gandini, M.A. Calderazzo, A. Profiti, F. Piedepalumbo, F. Blasi. - In: RESPIRATORY RESEARCH. - ISSN 1465-993X. - 26:1(2025 Jan 18), pp. 19.1-19.3. [10.1186/s12931-024-03089-2]
-
Respiratory Outcomes and Aspergillus Serology Following Elexacaftor/Tezacaftor/Ivacaftor Therapy in People with Cystic Fibrosis and a History of Aspergillus fumigatus Infection / C. Lanfranchi, G. Alicandro, L. Cariani, B.S. Orena, A. Gramegna, C. Rizza, F. Blasi, V. Daccò. - In: LUNG. - ISSN 0341-2040. - 203:1(2025 Jan 06), pp. 24.1-24.8. [10.1007/s00408-024-00781-4]
-
Impact of long-term high-flow nasal therapy on mucus plugs in patients with bronchiectasis / C. Crimi, S. Nolasco, R. Campisi, M. Nigro, P. Impellizzeri, A. Cortegiani, A. Noto, A. Gramegna, C. Vancheri, F. Blasi, N. Crimi, S. Aliberti, A. Carlucci. - In: ERJ OPEN RESEARCH. - ISSN 2312-0541. - 11:3(2025), pp. 1-5. [10.1183/23120541.00962-2024]
-
A nonnatural peptide targeting the A-kinase anchoring function of PI3Kγ for therapeutic cAMP modulation in pulmonary cells / A. Della Sala, L. Tasca, C. Butnarasu, V. Sala, G. Prono, A. Murabito, O.V. Garbero, E. Millo, L. Terranova, F. Blasi, A. Gramegna, S. Aliberti, A. Massarotti, S. Visentin, E. Hirsch, A. Ghigo. - In: THE JOURNAL OF BIOLOGICAL CHEMISTRY. - ISSN 0021-9258. - 300:11(2024 Nov), pp. 107873.1-107873.15. [10.1016/j.jbc.2024.107873]
-
Heterogeneity in response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis / G. Alicandro, A. Gramegna, F. Bellino, S.C. Sciarrabba, C. Lanfranchi, M. Contarini, M. Retucci, V. Daccò, F. Blasi. - In: JOURNAL OF CYSTIC FIBROSIS. - ISSN 1569-1993. - 23:6(2024 Nov), pp. 1072-1079. [10.1016/j.jcf.2024.04.013]